Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT01282827Not ApplicableCompleted

Paraorbital-Occipital Electric Stimulation in Patients With Optic Neuropathy (BCT_optnerve)

Role: collaborator

NCT01270126Not ApplicableCompleted

Trial of Alternating Current Stimulation in Optic Neuropathy

Role: collaborator

NCT01418820Phase 2Completed

Paraorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic Lesions

Role: collaborator

NCT01280877Not ApplicableCompleted

Paraorbital-Occipital Alternating Current Stimulation Therapy for Optic Neuropathy (MCT_optnerve)

Role: collaborator

NCT01277575Phase 3Terminated

Non-invasive Repetitive Paraorbital Alternating Current Stimulation Therapy for Aphasia

Role: collaborator

All 5 trials loaded